中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: A novel in vitro cholestatic model

文献类型:期刊论文

作者Ni, Xuan1,2; Gao, Yimeng3; Wu, Zhitao1,2; Ma, Leilei1,2; Chen, Chen1,2; Wang, Le1,2; Lin, Yunfei1,2; Hui, Lijian3; Pan, Guoyu1,2
刊名Scientific Reports
出版日期2016-12-09
卷号6
ISSN号2045-2322
DOI10.1038/srep38694
文献子类Article
英文摘要Drug-induced cholestasis is a leading cause of drug withdrawal. However, the use of primary human hepatocytes (PHHs), the gold standard for predicting cholestasis in vitro, is limited by their high cost and batch-to-batch variability. Mature hepatocyte characteristics have been observed in human induced hepatocytes (hiHeps) derived from human fibroblast transdifferentiation. Here, we evaluated whether hiHeps could biosynthesize and excrete bile acids (BAs) and their potential as PHH alternatives for cholestasis investigations. Quantitative real-time PCR (qRT-PCR) and western blotting indicated that hiHeps highly expressed BA synthases and functional transporters. Liquid chromatography tandem mass spectrometry (LC-MS/ MS) showed that hiHeps produced normal intercellular unconjugated BAs but fewer conjugated BAs than human hepatocytes. When incubated with representative cholestatic agents, hiHeps exhibited sensitive drug-induced bile salt export pump (BSEP) dysfunction, and their response to cholestatic agent-mediated cytotoxicity correlated well with that of PHHs (r(2) = 0.8032). Deoxycholic acid (DCA)-induced hepatotoxicity in hiHeps was verified by elevated aspartate aminotransferase (AST) and gamma-glutamyl-transferase (gamma-GT) levels. Mitochondrial damage and cell death suggested DCA-induced toxicity in hiHeps, which were attenuated by hepatoprotective drugs, as in PHHs. For the first time, hiHeps were reported to biosynthesize and excrete BAs, which could facilitate predicting cholestatic hepatotoxicity and screening potential therapeutic drugs against cholestasis.
WOS关键词INDUCED LIVER-INJURY ; CULTURED RAT HEPATOCYTES ; DRUG-INDUCED CHOLESTASIS ; PREGNANE-X-RECEPTOR ; HEPARG CELLS ; HEPATOBILIARY TRANSPORTERS ; BILIARY OBSTRUCTION ; DAMAGE ; TOXICITY ; CHOLESTEROL
资助项目National Science Foundation of China[81302836] ; National Science Foundation of China[81573499] ; National High Technology Research and Development Program of China[2013AA032202]
WOS研究方向Science & Technology - Other Topics
语种英语
WOS记录号WOS:000389542300001
出版者NATURE PUBLISHING GROUP
源URL[http://119.78.100.183/handle/2S10ELR8/275766]  
专题药物安全性评价中心
通讯作者Hui, Lijian; Pan, Guoyu
作者单位1.Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China;
2.Chinese Acad Sci, Shanghai Inst Mat Medica, Shanghai 201203, Peoples R China;
3.Shanghai Inst Biol Sci, Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China
推荐引用方式
GB/T 7714
Ni, Xuan,Gao, Yimeng,Wu, Zhitao,et al. Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: A novel in vitro cholestatic model[J]. Scientific Reports,2016,6.
APA Ni, Xuan.,Gao, Yimeng.,Wu, Zhitao.,Ma, Leilei.,Chen, Chen.,...&Pan, Guoyu.(2016).Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: A novel in vitro cholestatic model.Scientific Reports,6.
MLA Ni, Xuan,et al."Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: A novel in vitro cholestatic model".Scientific Reports 6(2016).

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。